NASDAQ:GILD
$83.73
(
0.132%
)
Friday, 27th Jan 2023
Gilead Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $82.11 | $88.29 | Friday, 27th Jan 2023 GILD stock ended at $83.73. This is 0.132% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.03% from a day low at $83.11 to a day high of $83.97. |
| 90 days | $77.16 | $89.74 | |
| 52 weeks | $57.17 | $89.74 |
Historical Gilead Sciences prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $83.33 | $83.97 | $83.11 | $83.73 | 4 104 482 |
| 2023-01-26 | $83.76 | $83.81 | $82.61 | $83.62 | 3 667 258 |
| 2023-01-25 | $84.15 | $84.55 | $83.56 | $84.07 | 3 892 073 |
| 2023-01-24 | $83.43 | $84.08 | $82.11 | $84.02 | 4 749 532 |
| 2023-01-23 | $82.76 | $84.38 | $82.42 | $83.23 | 5 672 555 |
| 2023-01-20 | $83.54 | $83.80 | $82.51 | $83.01 | 16 678 603 |
| 2023-01-19 | $84.17 | $84.58 | $83.25 | $83.62 | 6 922 528 |
| 2023-01-18 | $85.02 | $85.13 | $83.60 | $83.74 | 6 374 849 |
| 2023-01-17 | $86.05 | $86.37 | $85.36 | $85.41 | 5 959 800 |
| 2023-01-13 | $85.54 | $86.30 | $85.33 | $86.27 | 5 305 720 |
| 2023-01-12 | $86.50 | $86.59 | $85.08 | $85.72 | 6 013 300 |
| 2023-01-11 | $87.12 | $87.20 | $86.02 | $87.19 | 5 947 100 |
| 2023-01-10 | $85.20 | $87.53 | $84.86 | $87.14 | 5 034 520 |
| 2023-01-09 | $87.77 | $87.90 | $84.95 | $85.10 | 5 435 709 |
| 2023-01-06 | $86.61 | $88.29 | $86.22 | $88.08 | 5 939 400 |
| 2023-01-05 | $85.01 | $86.41 | $85.00 | $85.85 | 5 535 794 |
| 2023-01-04 | $86.20 | $86.50 | $84.94 | $85.50 | 5 704 623 |
| 2023-01-03 | $85.08 | $86.15 | $84.83 | $85.39 | 6 050 002 |
| 2022-12-30 | $85.33 | $85.89 | $84.78 | $85.85 | 3 804 364 |
| 2022-12-29 | $84.91 | $85.57 | $84.61 | $85.26 | 3 455 749 |
| 2022-12-28 | $85.40 | $85.83 | $84.45 | $84.57 | 3 210 584 |
| 2022-12-27 | $85.25 | $85.47 | $84.69 | $85.01 | 3 427 431 |
| 2022-12-23 | $85.22 | $85.25 | $84.28 | $84.75 | 3 611 873 |
| 2022-12-22 | $85.25 | $85.47 | $84.37 | $85.28 | 4 699 796 |
| 2022-12-21 | $85.25 | $85.91 | $84.86 | $85.27 | 5 320 945 |
| 2022-12-20 | $83.64 | $85.26 | $81.81 | $84.77 | 10 999 002 |
| 2022-12-19 | $86.00 | $86.62 | $85.43 | $86.42 | 5 834 828 |
| 2022-12-16 | $86.34 | $87.12 | $85.80 | $86.76 | 28 312 981 |
| 2022-12-15 | $88.05 | $88.10 | $85.39 | $86.58 | 9 898 601 |
| 2022-12-14 | $88.00 | $89.29 | $87.52 | $88.40 | 8 643 534 |
| 2022-12-13 | $89.63 | $89.74 | $87.94 | $88.75 | 8 462 162 |
| 2022-12-12 | $87.85 | $88.56 | $87.43 | $88.54 | 5 968 636 |
| 2022-12-09 | $89.27 | $89.27 | $87.79 | $87.97 | 8 276 293 |
| 2022-12-08 | $87.87 | $89.61 | $87.56 | $89.47 | 6 392 403 |
| 2022-12-07 | $88.03 | $88.55 | $87.37 | $87.79 | 8 861 858 |
| 2022-12-06 | $87.99 | $88.67 | $87.14 | $87.96 | 6 760 661 |
| 2022-12-05 | $87.84 | $89.10 | $87.47 | $87.98 | 6 811 532 |
| 2022-12-02 | $86.70 | $89.07 | $86.55 | $89.03 | 6 730 367 |
| 2022-12-01 | $88.20 | $88.97 | $87.72 | $87.90 | 8 220 595 |
| 2022-11-30 | $85.76 | $88.15 | $85.01 | $87.83 | 14 657 475 |
| 2022-11-29 | $85.50 | $85.87 | $84.71 | $85.76 | 6 155 566 |
| 2022-11-28 | $86.92 | $88.20 | $85.08 | $85.21 | 9 253 951 |
| 2022-11-25 | $85.04 | $86.41 | $84.76 | $86.26 | 4 028 739 |
| 2022-11-23 | $85.06 | $85.94 | $85.01 | $85.42 | 4 680 778 |
| 2022-11-22 | $84.65 | $86.15 | $84.54 | $85.23 | 7 357 716 |
| 2022-11-21 | $83.76 | $85.17 | $83.64 | $84.08 | 4 636 014 |
| 2022-11-18 | $83.63 | $84.06 | $82.99 | $83.63 | 3 690 850 |
| 2022-11-17 | $82.55 | $83.83 | $82.47 | $83.11 | 3 337 193 |
| 2022-11-16 | $82.68 | $83.44 | $82.54 | $83.02 | 3 642 343 |
| 2022-11-15 | $83.14 | $83.64 | $81.98 | $83.20 | 4 660 494 |
About Gilead Sciences
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, V... GILD Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
